Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B John

Showing results (521-530 of 612) with videos related to

Pageof 62
Sort By:
The American Journal of Cardiology|August 2, 2022
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramNathaniel R Smilowitz, Evan P Carey, Binita Shah, et al.
American Heart Journal|August 25, 2009
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 yearsChristopher E Buller, Jamie M Rankin, Ronald G Carere, et al.
The American Journal of Cardiology|July 6, 2010
Effect of a standardized radiation dose reduction protocol on diagnostic accuracy of coronary computed tomographic angiographyTroy M LaBounty, Jonathon Leipsic, G B John Mancini, et al.
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
Circulation|October 26, 2005
Coronary stent restenosis in patients treated with cilostazolJohn S Douglas, David R Holmes, Dean J Kereiakes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2008
Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trialVinod Jorapur, Terje K Steigen, Christopher E Buller, et al.
Clinical Rheumatology|January 10, 2020
Presence of active MRI lesions in patients suspected of non-radiographic axial spondyloarthritis with high disease activity and chance at conversion after a 6-month follow-up periodTamara Rusman, Marie-Luise B John, Mignon A C van der Weijden, et al.
Clinical Cardiology|March 7, 2016
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) TrialSteven E Nissen, Ricardo E Dent-Acosta, Robert S Rosenson, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable anginaZugui Zhang, Paul Kolm, William E Boden, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Pageof 62

Showing results (521-530 of 612) with videos related to

Sort By:
Pageof 62
The American Journal of Cardiology|August 2, 2022
Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramNathaniel R Smilowitz, Evan P Carey, Binita Shah, et al.
American Heart Journal|August 25, 2009
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 yearsChristopher E Buller, Jamie M Rankin, Ronald G Carere, et al.
The American Journal of Cardiology|July 6, 2010
Effect of a standardized radiation dose reduction protocol on diagnostic accuracy of coronary computed tomographic angiographyTroy M LaBounty, Jonathon Leipsic, G B John Mancini, et al.
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
Circulation|October 26, 2005
Coronary stent restenosis in patients treated with cilostazolJohn S Douglas, David R Holmes, Dean J Kereiakes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2008
Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trialVinod Jorapur, Terje K Steigen, Christopher E Buller, et al.
Clinical Rheumatology|January 10, 2020
Presence of active MRI lesions in patients suspected of non-radiographic axial spondyloarthritis with high disease activity and chance at conversion after a 6-month follow-up periodTamara Rusman, Marie-Luise B John, Mignon A C van der Weijden, et al.
Clinical Cardiology|March 7, 2016
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) TrialSteven E Nissen, Ricardo E Dent-Acosta, Robert S Rosenson, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable anginaZugui Zhang, Paul Kolm, William E Boden, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Pageof 62